In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

TearScience brings in $44.5mm in Series C money

Executive Summary

TearScience Inc. (devices to monitor and treat dry eye) has raised $44.5mm through its Series C venture round. New backers Essex Woodlands Health Ventures, Investor Growth Capital, and General Catalyst will each contribute one board member and were joined by returning shareholders De Novo Ventures, Spray Ventures, and Quaker BioVentures.
Deal Industry
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register